Andrew Dawdy is a seasoned professional in the field of analytical chemistry with a robust background in research and development. With experience ranging from an Analytical Chemistry Intern at Mallinckrodt Pharmaceuticals to a Senior Principal Scientist at Pfizer, Andrew has demonstrated expertise in method development, instrument validation, and protein characterization. Key achievements include leading formulation development yielding $3 million in annual sales at AnazaoHealth Corporation and enhancing analytical methods for the pharmaceutical industry. Educational qualifications include a Bachelor of Arts in Chemistry from Taylor University and a Doctor of Philosophy in Bioanalytical Chemistry from the University of Virginia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices